Patent ID: 9044449
Filing Date: 2015-06-02
Classification: A61K,A61P

Abstract:
1. A method of treating inflammation of the central nervous system (CNS) in a human in need thereof , comprising administering to the human in need thereof a composition comprising one or more X-ray contrast media in an amount sufficient to treat said inflammation of the CNS and zinc in an amount sufficient to activate an angiotensin converting enzyme (ACE), wherein the amount of zinc is from 0.1×10 −3 mg to 4×10 −3 mg, and wherein a) the X-ray contrast media comprises a triiodinated, benzene moiety; b) the X-ray contrast media is a non-ionic monometer, non-ionic dimer, ionic monomer or ionic dimer; and c) the composition is administered directly to CNS tissue.